SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-074352
Filing Date
2020-06-18
Accepted
2020-06-18 06:04:36
Documents
1
Period of Report
2020-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm2022841d3_form4.html 4  
1 FORM 4 tm2022841d3_form4.xml 4 3890
  Complete submission text file 0001104659-20-074352.txt   5400
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address
Wu Yue Alexander (Reporting) CIK: 0001682419 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 20971167